Liquid chromatography-mass spectrometry (LC–MS) growth lifts Waters Q3; MOBILion ion mobility buy expands proteomics.
|Articles|January 1, 2017
- LCGC Europe-01-01-2017
- Volume 30
- Issue 1
Vol 30 No 1 LCGC Europe January 2017 Regular Issue PDF
Click the title above to open the LCGC Europe January 2017 regular issue, Vol 30, No 1, in an interactive PDF format.
Advertisement
Articles in this issue
almost 10 years ago
Pittcon 2017 Hits Chicagoalmost 10 years ago
LC–MS Characterization of Mesquite Flour Constituentsalmost 10 years ago
Three Common SPE Problemsalmost 10 years ago
Take Control of Resolution (LCGC Europe)almost 10 years ago
Microextraction and Its Application to Forensic Toxicology Analysisalmost 10 years ago
Back to Basics: The Role of pH in Retention and SelectivityAdvertisement
Related to this article
Liquid chromatography–tandem mass spectrometry (LC–MS/MS) measures galactose-1-phosphate in dried blood spots to monitor galactosemia.
Sam Whitmarsh explores how retention-time models handle interlaboratory data, novel chemotypes, unusual phases and ionisable compounds, and what labs need to do to build useful in-house models.
Dual-column ultra-high-performance liquid chromatography-mass spectrometry (UHPLC-MS) reveals urine markers of apple intake lasting 24 hours.
Sam Whitmarsh describes a practical workflow for predicting reversed-phase LC retention times using ensemble machine learning and open chromatographic data.
This month's LCGC Blog explores the variety of career options that are open to separation scientists.
Optimized preparation and data-independent acquisition (DIA) liquid chromatography–mass spectrometry (LC-MS) detect up to 6500 proteins in laboratory-grown duck.
Advertisement
Advertisement
Trending on LCGC International
1
AI/ML Now: Predicting Reversed-Phase LC Retention Using Ensemble Machine Learning and Open Chromatographic Data (Part Two)
2
AI/ML Now: Predicting Reversed-Phase LC Retention Using Ensemble Machine Learning and Open Chromatographic Data (Part One)
3
From 9000 Clues to a Clinical Test: Mass Spectrometry-Driven Lipidomics for Early Cancer Detection
4
AI/ML Now: Toxicity Prediction for Unknown LC–HRMS Features Using Machine Learning
5